RETRACTION: Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting I κ B α /NF κ B and Enhancing Nrf2/HO‐1
Oxidative Medicine and Cellular Longevity · 2026-01 · 2026 (1)
DOI: 10.1155/omcl/9843608 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oxidative Medicine and Cellular Longevity, online erschienen am 09.11.2026. Verfasst von Oxidative Medicine And Cellular Longevity. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Cellular Longevity, O. M. A. (2026). RETRACTION: Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting I κ B α /NF κ B and Enhancing Nrf2/HO‐1. Oxidative Medicine and Cellular Longevity, 2026(1). https://doi.org/10.1155/omcl/9843608
Vancouver
Cellular Longevity OMA. RETRACTION: Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting I κ B α /NF κ B and Enhancing Nrf2/HO‐1. Oxidative Medicine and Cellular Longevity. 2026;2026(1). doi:10.1155/omcl/9843608
BibTeX
@article{CellularLongevity2026,
author = {Cellular Longevity, Oxidative Medicine And},
title = {RETRACTION: Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting I κ B α /NF κ B and Enhancing Nrf2/HO‐1},
journal = {Oxidative Medicine and Cellular Longevity},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/omcl/9843608}
}
EUVIMED